![Jörg W. Menten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörg W. Menten
Keine laufenden Positionen mehr
Profil
Jörg W.
Menten served as the Chief Executive Officer & Managing Director at SphingoTec GmbH from 2022 to 2024.
Prior to that, he was the Co-Chairman-Supervisory Board & CFO at Vanguard AG from 2009 to 2011.
From 2001 to 2007, he held the position of President-KCI International at Kinetic Concepts, Inc. Mr. Menten obtained an MBA from the University of Mannheim.
Ehemalige bekannte Positionen von Jörg W. Menten
| Unternehmen | Position | Ende |
|---|---|---|
SphingoTec GmbH
 SphingoTec GmbH BiotechnologyHealth Technology Develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function | Vorstandsvorsitzender | 26.03.2024 |
Vanguard AG
 Vanguard AG Miscellaneous Commercial ServicesCommercial Services Specializes in process optimization of medical devices | Vorsitzender | 24.11.2011 |
Kinetic Concepts, Inc.
 Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Corporate Officer/Principal | 30.04.2007 |
Ausbildung von Jörg W. Menten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Health Technology |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanguard AG
Vanguard AG Miscellaneous Commercial ServicesCommercial Services Specializes in process optimization of medical devices | Commercial Services |
SphingoTec GmbH
SphingoTec GmbH BiotechnologyHealth Technology Develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function | Health Technology |
